Literature DB >> 12681997

Absence of association between infectious agents and endothelial function in healthy young men.

Paul Khairy1, Stephane Rinfret, Jean-Claude Tardif, Richard Marchand, Stan Shapiro, James Brophy, Jocelyn Dupuis.   

Abstract

BACKGROUND: Although several studies have reported correlations between infections and coronary artery disease, associations with endothelial dysfunction, its precursor, have not been established. This study assessed whether infection with Chlamydia pneumoniae (CP), cytomegalovirus (CMV), Epstein-Barr virus (EBV), or Helicobacter pylori (HP) is associated with decreased endothelial function. METHODS AND
RESULTS: Sixty-five male subjects, aged 20 to 45 years, with no risk factors or known coronary artery disease were enrolled in a seroepidemiological cross-sectional study. Endothelial function was determined by flow-mediated brachial vasodilation. Serum antibodies consisting of anti-CP IgG and IgM, anti-CMV IgG, anti-EBV nuclear antigen, and anti-HP IgG and markers of inflammation including high-sensitivity C-reactive protein were measured. Average age was 29.3+/-5.5 years. Seroprevalence values were 65.1%, 34.9%, 88.9%, and 14.3% for CP, CMV, EBV, and HP, respectively. Average values for endothelium-dependent and -independent vasodilation were 9.4+/-4.5% and 12.6+/-5.0%. Despite adequate statistical power (82% for the primary end point), no association between endothelial function and seropositivity to individual infectious agents, infectious burden, or C-reactive protein was observed in regression analyses controlling for variables including age, blood pressure, and lipid parameters. Moreover, no dose-response trends between serum titers and endothelial function were found.
CONCLUSIONS: Lack of association between chronic infection with CP, CMV, EBV, HP, or pathogen burden and endothelial function was observed, suggesting that these agents are not implicated as early etiologic triggers in the genesis of coronary artery disease. These results do not preclude active involvement at later stages of the pathophysiological process, such as acceleration of existing atherosclerosis and acute plaque rupture.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12681997     DOI: 10.1161/01.CIR.0000064895.89033.97

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  13 in total

Review 1.  Infection and Stroke: an Update on Recent Progress.

Authors:  Eliza C Miller; Mitchell S V Elkind
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

2.  Cross-reactivity of anti-H pylori antibodies with membrane antigens of human erythrocytes.

Authors:  Feng-Hua Guo; Xiao-Mei Yan; Chun-Xiang Fan; Fei Zhao; Yuan Hu; Di Xiao; Xun Zeng; Mao-Jun Zhang; Li-Hua He; Fan-Ling Meng; Jian-Zhong Zhang
Journal:  World J Gastroenterol       Date:  2007-07-21       Impact factor: 5.742

Review 3.  Infectious serologies and autoantibodies in hepatitis C and autoimmune disease-associated mixed cryoglobulinemia.

Authors:  Merav Lidar; Noga Lipschitz; Nancy Agmon-Levin; Pnina Langevitz; Ori Barzilai; Maya Ram; Bat-Sheba Porat-Katz; Nicola Bizzaro; Jan Damoiseaux; Jan Willem Cohen Tervaert; Salvatore deVita; Stefano Bombardieri; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

4.  Productive Cytomegalovirus Infection Is Associated With Impaired Endothelial Function in ST-Elevation Myocardial Infarction.

Authors:  Anna Lebedeva; Elena Maryukhnich; Jean-Charles Grivel; Elena Vasilieva; Leonid Margolis; Alexander Shpektor
Journal:  Am J Med       Date:  2019-07-08       Impact factor: 4.965

5.  Deficit schizophrenia: association with serum antibodies to cytomegalovirus.

Authors:  Faith Dickerson; Brian Kirkpatrick; John Boronow; Cassie Stallings; Andrea Origoni; Robert Yolken
Journal:  Schizophr Bull       Date:  2005-09-15       Impact factor: 9.306

6.  Relation of high cytomegalovirus antibody titres to blood pressure and brachial artery flow-mediated dilation in young men: the Cardiovascular Risk in Young Finns Study.

Authors:  A Haarala; M Kähönen; T Lehtimäki; J Aittoniemi; J Jylhävä; N Hutri-Kähönen; L Taittonen; T Laitinen; M Juonala; J Viikari; O T Raitakari; M Hurme
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

7.  Individual pathogens, pathogen burden and markers of subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Moyses Szklo; Jingzhong Ding; Michael Y Tsai; Mary Cushman; Joseph F Polak; João Lima; R Graham Barr; A Richey Sharrett
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2009-10       Impact factor: 2.160

8.  Persistence of an atherogenic lipid profile after treatment of acute infection with Brucella.

Authors:  F Apostolou; I F Gazi; A Kostoula; C C Tellis; A D Tselepis; M Elisaf; E N Liberopoulos
Journal:  J Lipid Res       Date:  2009-06-17       Impact factor: 5.922

9.  Helicobacter pylori infection is identified as a cardiovascular risk factor in Central Africans.

Authors:  Benjamin Longo-Mbenza; Jacqueline Nkondi Nsenga; Etienne Mokondjimobe; Thierry Gombet; Itoua Ngaporo Assori; Jean Rosaire Ibara; Bertrand Ellenga-Mbolla; Dieudonné Ngoma Vangu; Simon Mbungu Fuele
Journal:  Vasc Health Risk Manag       Date:  2012-08-15

10.  Cytomegalovirus seropositivity is associated with increased arterial stiffness in patients with chronic kidney disease.

Authors:  Nadezhda A Wall; Colin D Chue; Nicola C Edwards; Tanya Pankhurst; Lorraine Harper; Richard P Steeds; Sarah Lauder; Jonathan N Townend; Paul Moss; Charles J Ferro
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.